RabiPlus-D Capsule PR
By RabiPlus-D
Rx
15 Capsule PR in a Strip

Composition
Domperidone(30mg) + Rabeprazole(20mg)

Manufacturer - Wanbury Ltd
Wanbury Limited , BSEL Techpark, 'B' Wing, 10th Floor, Sector 30-A, Opp. Vashi Railway Station, Vashi, Navi Mumbai - 400703, India.

Expires on or after
August, 2026

liver
When taking RabiPlus-D Capsule PR, it is important to be cautious if you have liver disease. Patients with liver issues may require adjustments to their dosage of RabiPlus-D Capsule PR, so it is essential to consult your doctor before using this medication. It is not advisable to use RabiPlus-D Capsule PR in patients with moderate to severe liver disease. If you have any concerns or liver-related issues, make sure to seek medical advice before starting treatment with RabiPlus-D Capsule PR.

kidney
It is important to use RabiPlus-D Capsule PR with caution in patients with kidney disease, as dose adjustment may be necessary. Please consult your doctor for proper guidance.

alcohol
When taking RabiPlus-D Capsule PR, be cautious when consuming alcohol and consult your doctor.

driving
When taking RabiPlus-D Capsule PR, be aware that it can reduce alertness, impact vision, and cause drowsiness or dizziness. Avoid driving if experiencing these effects.

pregnancy
RabiPlus-D Capsule PR may be unsafe during pregnancy. Animal studies show harmful effects on the developing baby. Consult your doctor before use, as they will consider the benefits and risks.

breastfeeding
RabiPlus-D Capsule PR is not recommended during breastfeeding as it may pass into breastmilk and possibly harm the baby. It's best to consult your doctor regarding the safety of using this medication while breastfeeding.
| Habit Forming | No |
| Chemical Class | - |
| Therapeutic Class | GASTRO INTESTINAL |
| Action Class | Proton pump inhibitors |
₹299.8
Inclusive of all taxes
Content verified by

Dr. Abdullah Khan
MBBS - General Medicine
Last update on 01-Oct-2024







